Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Sadif Analytics Prime
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioGaia AB says study shows it is possible to prevent common infections in children


Monday, 17 Mar 2014 04:00am EDT 

BioGaia AB:Says new study shows that it is possible to prevent common infections in children.Says healthy children attending day-care centers have a significantly lower risk of getting diarrhoea or respiratory tract infections when given a daily supplement of Lactobacillus reuteri Protectis, a study in 336 children shows.Says during three months’ long intervention the children receiving Lactobacillus reuteri Protectis had 67 pct fewer days with diarrhoea or respiratory tract infection than children in placebo group.Says when infected the episodes were also shorter than in the placebo group, diarrhoea was shortened by one day and duration of respiratory tract infection was three days shorter compared to placebo.Says children supplemented by Lactobacillus reuteri Protectis had fewer days with fever, used less antibiotics and were less absent from day-care.Says by calculating direct costs investigators demonstrated that daily use of Lactobacillus reuteri Protectis saves costs both for the family and community.Says the study was published in medical journal Pediatrics on March 17. 

Company Quote

193.0
-2.0 -1.03%
21 Nov 2014